184 related articles for article (PubMed ID: 761991)
21. Piperacillin: evaluation against inpatient and gentamicin-resistant bacteria.
Rosenthal SL; Freundlich LF; Rendler S; Winn R; Japko LI
Scand J Infect Dis; 1980; 12(2):136-8. PubMed ID: 6445587
[TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
Hoogkamp-Korstanje JA; Westerdaal NA
Chemotherapy; 1979; 25(1):48-53. PubMed ID: 253637
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
Høiby N; Bremmelgaard A; Schouenborg P
Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
[TBL] [Abstract][Full Text] [Related]
24. Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
Kohler RB; Foerster LA; Wheat LJ; Williams JM; Reynolds J; Norton J
Arch Intern Med; 1982 Jul; 142(7):1335-7. PubMed ID: 6212035
[TBL] [Abstract][Full Text] [Related]
25. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
Pickering LK; Rutherford I
J Pharmacol Exp Ther; 1981 May; 217(2):345-9. PubMed ID: 6453219
[TBL] [Abstract][Full Text] [Related]
26. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Reimer LG; Mirrett S; Reller LB
Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.
Klastersky J; Henri A; Vandenborre L
Am J Med Sci; 1973 Jul; 266(1):13-21. PubMed ID: 4198684
[No Abstract] [Full Text] [Related]
28. Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae.
Glew RH; Pavuk RA
Antimicrob Agents Chemother; 1983 Jun; 23(6):902-6. PubMed ID: 6225391
[TBL] [Abstract][Full Text] [Related]
29. [Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].
Kosakai N; Oguri T
Jpn J Antibiot; 1980 Jun; 33(6):668-74. PubMed ID: 6779031
[TBL] [Abstract][Full Text] [Related]
30. Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.
Watanakunakorn C; Glotzbecker C
J Antibiot (Tokyo); 1979 Oct; 32(10):1019-24. PubMed ID: 528361
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
Gootz TD; Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1979 Jun; 15(6):783-91. PubMed ID: 475364
[TBL] [Abstract][Full Text] [Related]
32. Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum.
Reyes MP; El-Khatib MR; Brown WJ; Smith F; Lerner AM
J Infect Dis; 1979 Aug; 140(2):192-202. PubMed ID: 113468
[TBL] [Abstract][Full Text] [Related]
33. [Comparative activity of new semisynthetic penicillins and their combinations with gentamycin against gram-negative bacteria].
Treskina OS; Slepchenko LM; Nasonov VN; Dutova EN
Antibiot Med Biotekhnol; 1987 Nov; 32(11):855-9. PubMed ID: 3439791
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of recent isolates of Pseudomonas aeruginosa to gentamicin, polymyxin, and five penicillins, with observations on the pyocin and immunotypes of the strains.
Adler JL; Finland M
Appl Microbiol; 1971 Nov; 22(5):870-5. PubMed ID: 4332044
[TBL] [Abstract][Full Text] [Related]
35. In vitro effects of carbenicillin combined with gentamicin or polymyxin B against Pseudomonas aeruginosa.
Eickhoff TC
Appl Microbiol; 1969 Sep; 18(3):469-73. PubMed ID: 4313764
[TBL] [Abstract][Full Text] [Related]
36. Preliminary report comparing piperacillin and carbenicillin for complicated urinary tract infections.
Swarifi R; Lee M; Ojeda L; Tabib M
J Urol; 1982 Oct; 128(4):755-8. PubMed ID: 6216344
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of carbenicillin, ticarcillin, sisomicin and netilmicin alone and in combination against Pseudomonas aeruginosa.
Watanakunakorn C; Glotzbecker C
Chemotherapy; 1978; 24(6):343-6. PubMed ID: 100282
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
Klastersky J; Nyamubeya B; Vandenborre L
J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
[No Abstract] [Full Text] [Related]
39. Effectiveness of gentamicin and carbenicillin in a rat model against infections with Pseudomonas aeruginosa resistant to gentamicin or gentamicin and carbenicillin.
Khakoo RA; Kluge RM
J Antimicrob Chemother; 1979 Jan; 5(1):53-9. PubMed ID: 104952
[No Abstract] [Full Text] [Related]
40. Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease.
Thompson MI; Russo ME; Saxon BJ; Atkin-Thor E; Matsen JM
Antimicrob Agents Chemother; 1982 Feb; 21(2):268-73. PubMed ID: 6462107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
